Innovative saliva-based health diagnostic tools will be developed by researchers at the University of Texas at Austin through a $6 million, multi-institutional grant from the National Institutes of Health.
Using a mesh tube to hold open partly blocked brain arteries reduced stroke risk, possibly more than with drug therapy with aspirin or warfarin, researchers reported at the American Stroke Association?s International Stroke Conference 2007.
Half the people experiencing stroke symptoms ? especially those with lower incomes ? don?t seek medical treatment, researchers reported at the American Stroke Association?s International Stroke Conference 2007.
Proacta Therapeutics, a spin-out company of The University of Auckland, has raised US$35 million (NZ$51 million) in venture capital to continue its research into potential treatments for cancer.
It is estimated that more than one million burn injuries occur every year and of that, 50 percent could be avoided. Burn Awareness Week, observed the first full week in February each year, is an opportunity to remind parents and children about potential hazards that can lead to burns in the home.
A University of Adelaide cardiologist has saved the life of a 70-year-old Adelaide woman after performing a world first operation to repair a tear in her heart.
The AIDS Healthcare Foundation banned all Pfizer drug reps from its 14 clinic facilities on Thursday because it believes Pfizer is promoting Viagra in a way that encourages irresponsible use of the drug among crystal meth users.
Four of the nation?s leading biomedical research institutions have announced the formation of the San Diego Research Ethics Consortium, a multi-institution core resource to support the ethical conduct of science in stem cell and other research programs.
With Valentine?s Day (February 14) right around the corner, the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) would like to remind you that snoring may lead to the demise of your relationship?and your Valentine might be best served by some preventive measures.
A study led by researchers at Dana-Farber Cancer Institute and Broad Institute of the Massachusetts Institute of Technology and Harvard University provides the first demonstration of a practical method of screening tumors for cancer-related gene abnormalities that might be treated with “targeted” drugs.